OTLC
Oncotelic Therapeutics Inc

11,215
Mkt Cap
$16.61M
Volume
535,780.00
52W High
$0.11
52W Low
$0.015
PE Ratio
0.07
OTLC Fundamentals
Price
$0.0374
Prev Close
$0.0356
Open
$0.0356
50D MA
$0.0394
Beta
0.01
Avg. Volume
340,253.50
EPS (Annual)
$0.592
P/B
0.06
Rev/Employee
$0.00
$46.13
Loading...
Loading...

About

Oncotelic Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of anti-vascular therapeutics for patients with cancer and sight-threatening eye diseases. It also develops OT-101 for various cancers and COVID-19, Artemisinin for COVID-19 and AI technologies for clinical development and manufacturing. The company was founded in 1988 and is headquartered in Agoura Hills, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
56

Frequently Asked Questions

What is Market Cap of Oncotelic Therapeutics Inc?
What is the 52-week high for Oncotelic Therapeutics Inc?
What is the 52-week low for Oncotelic Therapeutics Inc?
What is Oncotelic Therapeutics Inc stock price today?
What was Oncotelic Therapeutics Inc stock price yesterday?
What is the PE ratio of Oncotelic Therapeutics Inc?
What is the Price-to-Book ratio of Oncotelic Therapeutics Inc?
What is the 50-day moving average of Oncotelic Therapeutics Inc?
How many employees does Oncotelic Therapeutics Inc have?

Latest OTLC News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.